Improper sample storage during deviation investigation – preventing false OOS results


Published on 26/04/2026

Addressing Improper Sample Storage in Deviation Investigations to Avoid False OOS Results

In the pharmaceutical manufacturing industry, the integrity of raw materials is vital for ensuring product quality. Improper sample storage can lead to inaccuracies in testing, resulting in false Out-Of-Specification (OOS) results. Such discrepancies may trigger costly investigations and compliance issues, ultimately impacting patient safety and regulatory standing. In this article, we will explore the investigation workflow for scenarios concerning improper sample storage, providing a clear, systematic approach to manage root cause analysis effectively.

By following this guide, readers will gain a detailed understanding of the signals indicative of storage errors, the potential causes, and the necessary data collection methods. We will outline the appropriate investigation tools and corrective and preventive actions (CAPA) strategies to mitigate the risk of repeated errors, ensuring your practices align with Good Manufacturing Practices (GMP).

Symptoms/Signals on the Floor or in the Lab

The first step

in addressing improper sample storage is recognizing the symptoms that indicate potential risks. These symptoms can manifest in various ways:

  • Testing Anomalies: Outlier results observed during quality control testing may suggest that stored samples have degraded due to improper conditions.
  • Sample Discrepancies: Reporting inconsistencies between taken samples and inventory records can signal storage issues.
  • User Feedback: Staff may report observations related to the physical condition of samples (e.g., discoloration, changes in texture).
  • Environmental Indicators: Monitoring equipment displays temperature or humidity deviations outside specified ranges.

Establishing a robust reporting culture is essential to ensure that observable symptoms are relayed efficiently to quality assurance teams for timely investigation. As symptoms may arise from multiple sources, timely identification can prevent unnecessary escalation.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

To navigate toward a root cause, it is essential to categorize potential sources of the symptom signals:

Category Possible Causes
Materials Supplier variability, improper labeling, poor quality of raw materials.
Method Inadequate Standard Operating Procedures (SOPs), improper handling procedures.
Machine Malfunctioning storage equipment (e.g., fridges, freezers), lack of alarms for deviations.
Man Insufficient training, negligence in following protocol.
Measurement Uncalibrated measurement tools affecting data accuracy.
Environment Temperature fluctuations due to inadequate facilities, exposure to light, or moisture.

Understanding these categories assists teams in systematically exploring possible causes and finding effective solutions in subsequent steps. Each cause should be considered thoroughly to avoid overlooking critical elements.

Pharma Tip:  Sampling SOP not followed during supplier complaint review – preventing false OOS results

Immediate Containment Actions (first 60 minutes)

Upon identification of abnormal results or reports, the first 60 minutes are crucial for containment. The following actions should be undertaken immediately:

  • Isolate Affected Samples: Remove any suspect samples from the storage unit and label them as “under investigation.” This will prevent further testing or use.
  • Review Storage Logs: Collect records of environmental conditions (temperature, humidity) during the period when the samples were stored.
  • Notify Relevant Departments: Inform quality control, quality assurance, and production teams of the issue to prevent downstream impacts.
  • Initiate an Internal Review: Conduct a preliminary assessment of standard procedures linked to sample handling and storage protocols.

These containment actions are not only critical for minimizing potential impact but also serve as documentation of immediate response in compliance with GMP requirements.

Investigation Workflow (data to collect + how to interpret)

Once initial containment actions are taken, a structured investigation workflow should be initiated. Data collection should include the following components:

  • Sample Documentation: Gather all relevant records related to sample acquisition, including batch numbers, vendor information, and quality specifications.
  • Environmental Monitoring Logs: Collect data from environmental monitoring devices, focusing on storage conditions, ensuring they align with established limits.
  • Personnel Interviews: Conduct interviews with staff involved in the sampling process for insights into their adherence to protocols.
  • Testing History: Review records of the assays performed on affected samples, documenting results and methods used.

Interpreting this data is essential; discrepancies between expected norms and recorded data can reveal critical insights to the failure modes present. A thorough analysis will help build a timeline of events leading up to the incident.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Addressing improper sample storage necessitates appropriate root cause analysis tools. Here are several methods to consider:

  • 5-Why Analysis: This tool is effective when the symptoms are fairly straightforward. It involves asking “why” multiple times (typically five) until the root cause is reached. This method promotes deep thinking and identifies underlying issues.
  • Fishbone Diagram (Ishikawa): Useful for categorizing potential causes, especially in complex scenarios. It encourages brainstorming with team members and mapping out causes in categories (Materials, Methods, Machines, etc.), allowing for visual insight into potential areas of failure.
  • Fault Tree Analysis: This approach is beneficial when specific failures lead to an undesired event. By illustrating pathways to failure, it allows teams to prioritize risks based on their likelihood and severity.

Choosing the right tool will depend on context; using a combination often yields the best results in identifying root causes effectively and thoroughly.

CAPA Strategy (correction, corrective action, preventive action)

A well-defined Corrective and Preventive Action (CAPA) strategy is vital in response to improper sample storage. Here are the three key components:

  • Correction: Immediate actions to rectify the error should be done. This may involve re-testing the affected samples under controlled conditions and disposing of any that are confirmed as compromised.
  • Corrective Action: Addressing the systematic issues that led to improper storage, such as revising training programs, ensuring improved labeling and handling procedures, and possibly upgrading storage equipment or systems.
  • Preventive Action: Making modifications to standard operating procedures (SOPs) and practice monitoring plans to reduce risks of recurrence. Strategies may include regular audits of storage protocols and improved staff training on protocol compliance.
Pharma Tip:  Non-representative sampling detected during regulatory inspection – inspection-ready sampling justification

A successful CAPA strategy not only corrects the identified defects but also builds resilience against future risks while ensuring compliance with GMP standards.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

After implementing corrective measures, establishing a control strategy is critical to prevent future incidents. A few strategies include:

  • Statistical Process Control (SPC): Utilize control charts to monitor environmental conditions of storage areas continuously. Set alarms for deviations to allow real-time alerts when conditions exceed defined acceptable ranges.
  • Routine Trending Analysis: Analyze historical data trends, particularly regarding sample stability and test results to identify patterns that may indicate storage issues over time.
  • Regular Sampling Plans: Design sampling plans to evaluate the integrity of storage conditions regularly, adding layers of assurance for the quality of incoming materials.
  • Verification Procedures: Implement verification steps within the process, ensuring compliance through routine audits and reconciliations of sample inventories with stored conditions.

A robust control strategy lays the foundation for operational excellence and compliance with regulatory expectations.

Related Reads

Validation / Re-qualification / Change Control impact (when needed)

As the investigation concludes and improvements are made, it’s crucial to consider validation and change control implications:

  • Validation Needs: If storage conditions or equipment are changed, validation protocols must be initiated to ensure that the changes meet all quality requirements.
  • Re-qualification of Suppliers: Evaluate suppliers for compliance with agreed storage conditions, as improper handling on their end can contribute to incidents.
  • Change Control Documentation: Record changes in procedures, including revised SOPs, and ensure all impacted departments acknowledge and align with these adjustments.

Timely validation, re-qualification, and comprehensive change control practices minimize the risks associated with improper sample storage and promote transparency across the organization.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

To maintain high levels of inspection readiness, documentation and evidence collection are essential. Be prepared to present:

  • Change Control Documentation: Records of all changes made during CAPA implementation. This should include any amendments to SOPs regarding sample storage protocols.
  • Environmental Monitoring Logs: Evidence of controlled environmental conditions and supporting data that demonstrate compliance during storage periods.
  • Batch Records: Documentation demonstrating traceability and quality associated with raw materials involved in the investigation.
  • Investigation Reports: Comprehensive reports detailing the investigation processes, findings, and actions taken can substantiate compliance efforts.
Pharma Tip:  Improper sample storage during internal audit – preventing false OOS results

Demonstrating thorough documentation of processes not only establishes compliance but also ensures that your organization is prepared for scrutiny, reducing the risk of regulatory penalties.

FAQs

What are the signs of improper sample storage?

Signs include testing anomalies, discrepancies in sample reports, and environmental monitoring logs showing deviations from set parameters.

How can 5-Why analysis help in investigations?

The 5-Why analysis helps identify root causes by encouraging deeper exploration of underlying issues through repetitive questioning.

What role does environmental monitoring play in sample integrity?

Environmental monitoring ensures that storage conditions are maintained within the required limits, safeguarding the integrity of samples over time.

What are proactive steps to implement in response to improper storage incidents?

Proactive steps include enhancing training, revising SOPs, and developing robust monitoring systems to ensure compliance and avoid recurrence.

What documentation is critical during an investigation?

Key documentation includes investigation reports, environmental logs, change control records, and batch documentation related to the samples in question.

How often should supplier qualifications be reviewed?

Supplier qualifications should be reviewed periodically, or whenever a significant change occurs in the supplier’s operations or storage practices.

What is the importance of CAPA in pharmaceutical manufacturing?

CAPA is essential for addressing non-conformities effectively to prevent future occurrences, ensuring compliance with regulatory requirements and maintaining product quality.

How can routine auditing contribute to inspection readiness?

Routine audits help identify potential compliance gaps proactively, ensuring that processes align with GMP and reducing risk during inspections.

What is the fault tree analysis method?

Fault tree analysis visually maps out potential failure paths that lead to a specific undesired event, enabling teams to prioritize and mitigate risks effectively.

How can organizations improve their sample handling protocols?

Organizations can improve protocols through comprehensive training, regular reviews of SOPs, and leveraging technology such as alarms and monitoring software.

What is the significance of the Fishbone diagram in root cause analysis?

The Fishbone diagram visually organizes potential causes for a specific issue, facilitating collaborative brainstorming to assess complex, multi-faceted problems.

When should validation procedures be initiated?

Validation procedures should be initiated when changes are made to processes, equipment, or storage conditions to ensure compliance with established quality requirements.